CONTRIBUTING TO DECARBONIZE MEDICAL GASES WITH ECO ORIGIN™
Globally, the healthcare sector represents around 4% of CO₂ emissions(1), prompting many countries to set specific decarbonization targets for healthcare facilities. In response to this growing demand, Air Liquide launched ECO ORIGIN™, a lowcarbon medical gas offer designed to help hospitals reduce the carbon footprint of their oxygen and nitrogen supplies.
Launched in early 2024, ECO ORIGIN™ provides certified low-carbon liquid medical gases, produced using 100% renewable electricity and supported by more efficient logistics, including route optimization and the use of alternative fuels where possible. This comprehensive approach enables hospitals to reduce the carbon footprint of their medical gas supply by more than 70%(2) on average compared with standard supply models, while ensuring the same quality and safety of supply. The offer also includes full traceability of emissions, from medical gas production to delivery, in line with ISO standards.
Since its launch, ECO ORIGIN™ has been adopted by nearly 150 hospitals and clinics, mainly across Europe, including Germany, Belgium, Spain, France, Italy and the Netherlands. By combining certified reductions in the carbon footprint of medical gases, the offer responds to growing expectations that healthcare providers reduce emissions without compromising patient care. More broadly, its rapid, multi-country deployment illustrates how targeted changes to essential hospital resources can advance environmental goals in healthcare delivery.
-70% average reduction in medical gas supply carbon footprintwith ECO ORIGIN™
A MULTIDIMENSIONAL GROWTH STRATEGY IN HOME HEALTHCARE
Beyond hospitals, demographic trends and the growing prevalence of chronic diseases are accelerating demand for home-based care solutions. Across Europe, healthcare systems are increasingly turning to home healthcare services to improve patient quality of life, ease pressure on hospitals, and manage costs more effectively. Air Liquide is strengthening its Home Healthcare (HHC) activities across several European countries, combining geographic expansion, large-scale public contracts, and personalized and digitally-enabled care models.
GERMANY: EXPANDING HOME HEALTHCARE THROUGH TARGETED ACQUISITIONS
In Germany, more than 23% of the population is now over the age of 65(3), while the healthcare system faces growing caregiver shortages, especially among nursing staff. In this context, the Group has acquired several specialized providers, including intensivLeben, AP Sachsen in Saxony, CareBerlin24 and CareBrandenburg24 in the Berlin area. These acquisitions add about 15 medically supervised residential care centers, operated by about 230 employees, mainly nurses, to Air Liquide’s German healthcare network.
These acquisitions expand Air Liquide’s footprint in regions with high population density and growing medical needs, while reinforcing a care model that prioritizes proximity, continuity, and individualized support for patients with complex conditions.
SPAIN: A LARGE-SCALE HOME RESPIRATORY CARE CONTRACT
According to the World Health Organization and the European Respiratory Society (ERS), the number of people living with chronic obstructive pulmonary disease (COPD) is expected to increase by 23% globally by 2050(4), highlighting the growing need for structured, long-term respiratory care.
In September 2025, the Community of Madrid awarded Air Liquide a five-year public contract to provide at-home care services to 70,000 patients living with respiratory diseases, following a competitive tender process. This contract covers patients suffering from conditions such as COPD and sleep apnea, with care delivered directly at home.
The care model combines in-person visits, teleconsultations, connected medical devices, and remote monitoring applications. A secure patient portal supports ongoing follow-up, while a mobile application, already used by 100,000 patients, helps people manage their treatment and alerts care teams to changes in patient status. Used alongside regular in-person interaction between patients and healthcare professionals, these technology solutions support continuity of care between scheduled visits while helping contain healthcare spending.